Shanghai Pharmaceuticals Revises Vote Data on 2025 Profit Distribution Plan

Shanghai Pharmaceuticals Holding Co., Ltd. has issued a clarification to its earlier disclosure on the voting results for its 2025 profit distribution plan at the annual general meeting. The company corrected the reported vote breakdown for A share and total ordinary share holders, noting that the clarification does not affect any other information in the original announcement.

The revised figures show substantially lower support among A share investors for the proposed profit distribution plan than previously reported, with a significant proportion voting against. While H share holders remain almost unanimously in favour, the corrected data may prompt closer scrutiny of shareholder sentiment and governance disclosures at the company.